Posted by Michael Wonder on 27 Mar 2023
Finerenone for the treatment of chronic kidney disease in patients with type 2 diabetes
23 March 2023 - NICE has issued evidence-based recommendations on the use of finerenone (Kerendia) for the treatment of adults with chronic kidney disease associated with type 2 diabetes.
Finerenone is recommended as an option for the treatment of certain adults with stage 3 and 4 chronic kidney disease (with albuminuria) associated with type 2 diabetes mellitus.
